AAAAAA
Results:
1-14
|
Results: 14
Authors:
BHARGAVA P
MARSHALL J
DAHUT W
RIZVI N
DORDAL M
SAMARA E
ELSHOURBAGY T
NESS E
BISCHOFF J
HAWKINS M
Citation: P. Bhargava et al., PHASE-I STUDY OF CEP-2563 DIHYDROCHLORIDE IN PATIENTS WITH ADVANCED CANCER, Annals of oncology, 9, 1998, pp. 424-424
Authors:
MAUER AM
VOGELZANG NJ
JANISH L
MANI S
SAMARA E
RATAIN MJ
Citation: Am. Mauer et al., PHASE-I STUDY OF CEP-2563 DIHYDROCHLORIDE (CEP-2563), A TYROSINE KINASE INHIBITOR, IN PATIENTS WITH SOLID TUMORS, Annals of oncology, 9, 1998, pp. 489-489
Authors:
SAMARA E
GRANNEMAN R
Citation: E. Samara et R. Granneman, ROLE OF POPULATION PHARMACOKINETICS IN DRUG DEVELOPMENT - A PHARMACEUTICAL-INDUSTRY PERSPECTIVE, Clinical pharmacokinetics, 32(4), 1997, pp. 294-312
Authors:
SAMARA E
CAO GL
LOCKE C
GRANNEMAN GR
DEAN R
KILLIAN A
Citation: E. Samara et al., POPULATION ANALYSIS OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SERATRODAST IN PATIENTS WITH MILD-TO-MODERATE ASTHMA, Clinical pharmacology and therapeutics, 62(4), 1997, pp. 426-435
Authors:
SAMARA E
GRANNEMAN R
LOCKE C
DEAN R
KILLIAN T
Citation: E. Samara et al., PK AND PD OF SERATRODAST IN PATIENTS WITH MODERATE ASTHMA, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 81-81
Authors:
SAMARA E
GRANNEMAN R
Citation: E. Samara et R. Granneman, PK-PD OF SERTINDOLE IN SCHIZOPHRENIC-PATIENTS, Clinical pharmacology and therapeutics, 59(2), 1996, p.
Authors:
SAMARA E
AVNIR D
LADKANI D
BIALER M
Citation: E. Samara et al., PHARMACOKINETIC ANALYSIS OF DIETHYLCARBONATE PRODRUGS OF IBUPROFEN AND NAPROXEN, Biopharmaceutics & drug disposition, 16(3), 1995, pp. 201-210
Authors:
SAMARA E
GRANNEMAN R
SAULIS R
WITT G
Citation: E. Samara et al., PHARMACOKINETIC-PHARMACODYNAMIC INTERACTION BETWEEN VALPROATE AND LORAZEPAM, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 153-153
Authors:
CAVANAUGH J
SAMARA E
EASON C
ACHARI R
HOSMANE B
SCHNECK D
Citation: J. Cavanaugh et al., LACK OF ADVERSE PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN TERAZOSIN AND FINASTERIDE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 171-171
Authors:
BIALER M
HADAD S
GOLOMB G
BAREL S
SAMARA E
ABUSALACH O
BERKMAN N
DANENBERG HD
BENDAVID J
CARON D
KAPLAN R
TAMIR A
FRIEDMAN M
Citation: M. Bialer et al., PHARMACOKINETIC ANALYSIS OF 2 NEW SUSTAINED-RELEASE PRODUCTS OF DILTIAZEM DESIGNED FOR TWICE-DAILY AND ONCE-DAILY TREATMENT, Biopharmaceutics & drug disposition, 15(1), 1994, pp. 45-52
Authors:
HUSSEIN Z
SAMARA E
LOCKE CS
ORCHARD MA
RINGHAM GL
GRANNEMAN GR
Citation: Z. Hussein et al., CHARACTERIZATION OF THE PHARMACOKINETICS AND PHARMACODYNAMICS OF A NEW ORAL THROMBOXANE A(2)-RECEPTOR ANTAGONIST AA-2414 IN NORMAL SUBJECTS- POPULATION ANALYSIS, Clinical pharmacology and therapeutics, 55(4), 1994, pp. 441-450
Authors:
SAMARA E
GRANNEMAN R
DUBE L
Citation: E. Samara et al., MICHAELIS-MENTEN KINETICS DETERMINE METABOLIC INTERACTION BETWEEN ZILEUTON AND PHENYTOIN - A POPULATION APPROACH, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 140-140
Authors:
HUSSEIN Z
GRANNEMAN GR
MUKHERJEE D
SAMARA E
HOGAN DL
KOSS MA
ISENBERG JI
Citation: Z. Hussein et al., AGE-RELATED DIFFERENCES IN THE PHARMACOKINETICS AND PHARMACODYNAMICS OF LANSOPRAZOLE, British journal of clinical pharmacology, 36(5), 1993, pp. 391-398
Authors:
SAMARA E
BIALER M
HARVEY DJ
Citation: E. Samara et al., METABOLISM OF CANNABIDIOL BY THE RAT, European journal of drug metabolism and pharmacokinetics, 16(4), 1991, pp. 305-313
Risultati:
1-14
|